• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物可减少心力衰竭患者以及接受心脏再同步化治疗和植入式心脏复律除颤器联合治疗患者的适当心脏复律除颤器电击次数及死亡率。

Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.

作者信息

Desai Harit, Aronow Wilbert S, Tsai Fausan S, Ahn Chul, Lai Hoang M, Amin Harshad, Gandhi Kaushang, Frishman William H, Cohen Martin, Sorbera Carmine

机构信息

Department of Medicine, New York Medical College, Valhalla, 10595, USA.

出版信息

J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):176-9. doi: 10.1177/1074248409340157. Epub 2009 Jul 17.

DOI:10.1177/1074248409340157
PMID:19617418
Abstract

Of 209 patients with heart failure treated with combined cardiac resynchronization therapy and implantable cardioverter-defibrillator therapy, appropriate cardioverter-defibrillator shocks occurred at 34-month follow-up in 22 of 121 patients (18%) on statins and in 30 of 88 patients (34%) not on statins (P = .009). Deaths occurred in 3 of 121 patients (2%) on statins and in 9 of 88 patients (10%) not on statins (P = .017). Stepwise Cox regression analysis showed that significant independent prognostic factors for appropriate shocks were use of statins (risk ratio = 0.46), smoking (risk ratio = 3.5), and diabetes (risk ratio = 0.34). Significant independent prognostic factors for the time to mortality were use of statins (risk ratio = 0.05), use of digoxin (risk ratio = 4.2), systemic hypertension (risk ratio = 14.2), diabetes (risk ratio = 4.3), and left ventricular ejection fraction (risk ratio = 1.1).

摘要

在209例接受心脏再同步治疗和植入式心律转复除颤器治疗的心力衰竭患者中,在34个月的随访中,121例服用他汀类药物的患者中有22例(18%)发生了适当的心律转复除颤器电击,而88例未服用他汀类药物的患者中有30例(34%)发生了适当的电击(P = 0.009)。服用他汀类药物的121例患者中有3例(2%)死亡,未服用他汀类药物的88例患者中有9例(10%)死亡(P = 0.017)。逐步Cox回归分析显示,适当电击的显著独立预后因素为服用他汀类药物(风险比 = 0.46)、吸烟(风险比 = 3.5)和糖尿病(风险比 = 0.34)。死亡时间的显著独立预后因素为服用他汀类药物(风险比 = 0.05)、使用地高辛(风险比 = 4.2)、系统性高血压(风险比 = 14.2)、糖尿病(风险比 = 4.3)和左心室射血分数(风险比 = 1.1)。

相似文献

1
Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.他汀类药物可减少心力衰竭患者以及接受心脏再同步化治疗和植入式心脏复律除颤器联合治疗患者的适当心脏复律除颤器电击次数及死亡率。
J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):176-9. doi: 10.1177/1074248409340157. Epub 2009 Jul 17.
2
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.心力衰竭患者接受心脏再同步化加植入型心律转复除颤器治疗与单独植入型心律转复除颤器治疗相比,恰当的心律转复除颤器电击次数和死亡率的发生率。
J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):37-40. doi: 10.1177/1074248409351408. Epub 2009 Dec 4.
3
Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.549 例心力衰竭患者中,心脏转复除颤器恰当电击、不恰当电击及死亡时间的危险因素。
Am J Cardiol. 2010 May 1;105(9):1336-8. doi: 10.1016/j.amjcard.2009.12.057. Epub 2010 Mar 11.
4
Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.心力衰竭与植入式心脏复律除颤器患者的电击风险:室性心律失常触发因素(TOVA)研究结果
Circulation. 2004 Mar 23;109(11):1386-91. doi: 10.1161/01.CIR.0000120703.99433.1E. Epub 2004 Mar 1.
5
Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.预测心力衰竭患者接受心脏再同步治疗后的合适除颤治疗。
Am J Cardiol. 2010 Jan 1;105(1):105-11. doi: 10.1016/j.amjcard.2009.08.659. Epub 2009 Nov 18.
6
Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.右心室起搏是植入式心脏复律除颤器患者发生室性心动过速/心室颤动及心力衰竭事件的独立预测因素。
Europace. 2008 Mar;10(3):358-63. doi: 10.1093/europace/eun019.
7
Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy.在接受再同步治疗的晚期心力衰竭患者中,使用他汀类药物与生存率提高相关。
Congest Heart Fail. 2009 Jul-Aug;15(4):159-64. doi: 10.1111/j.1751-7133.2009.00057.x.
8
Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.升级为心脏再同步治疗对植入式心律转复除颤器患者室性心律失常发生率的影响。
J Am Coll Cardiol. 2005 Dec 20;46(12):2258-63. doi: 10.1016/j.jacc.2005.04.067.
9
Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.多中心自动除颤器植入试验(MADIT-II)中他汀类药物对室性快速性心律失常的影响。
J Am Coll Cardiol. 2006 Feb 21;47(4):769-73. doi: 10.1016/j.jacc.2005.09.053. Epub 2006 Jan 30.
10
Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.心脏再同步化治疗加除颤器治疗患者纽约心脏协会心功能分级变化与室性快速心律失常发生之间的关系
Europace. 2009 Jan;11(1):80-5. doi: 10.1093/europace/eun288. Epub 2008 Oct 24.

引用本文的文献

1
Effect of Digitalis on ICD or CRT-D Recipients: A Systematic Review and Meta-Analysis.洋地黄对植入式心律转复除颤器(ICD)或心脏再同步化治疗除颤器(CRT-D)接受者的影响:一项系统评价和荟萃分析。
J Clin Med. 2023 Feb 20;12(4):1686. doi: 10.3390/jcm12041686.
2
Influence of diabetes on mortality and ICD therapies in ICD recipients: a systematic review and meta-analysis of 162,780 patients.糖尿病对 ICD 患者死亡率和 ICD 治疗的影响:一项纳入 162780 例患者的系统评价和荟萃分析。
Cardiovasc Diabetol. 2022 Jul 29;21(1):143. doi: 10.1186/s12933-022-01580-y.
3
Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias.
他汀类药物治疗与室性心律失常患者的生存改善相关。
Lipids Health Dis. 2019 May 24;18(1):119. doi: 10.1186/s12944-019-1011-x.
4
Drug Therapy of Dyslipidemia in the Elderly.老年人血脂异常的药物治疗
Drugs Aging. 2019 Apr;36(4):321-340. doi: 10.1007/s40266-018-00632-x.
5
Lipid-lowering therapy in older persons.老年人的降脂治疗。
Arch Med Sci. 2015 Mar 16;11(1):43-56. doi: 10.5114/aoms.2015.48148. Epub 2015 Jan 8.
6
Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry.阿托伐他汀治疗与射血分数降低的慢性心力衰竭患者的预后改善相关:Daunia 心力衰竭注册研究结果。
Neth Heart J. 2013 Sep;21(9):408-16. doi: 10.1007/s12471-013-0430-y.